|
EP2425821B1 |
10 May, 2017
|
Pharmaceutical Preparation Containing Oxycodone And Naloxone
|
Apr, 2023
|
11
| |
|
EP2425824B1 |
10 May, 2017
|
Pharmaceutical Preparation Containing Oxycodone And Naloxone
|
Apr, 2023
|
11
| |
|
EP2962686B1 |
10 Apr, 2019
|
Dosage Form Containing Oxycodone And Naloxone
|
Feb, 2026
|
7
| |
|
EP3578173B1 |
26 Oct, 2022
|
Dosage Form Containing Oxycodone And Naloxone
|
Feb, 2026
|
5
| |
|
EP1731152B1 |
01 May, 2013
|
Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine
|
Feb, 2018
|
3
| |
|
EP3024461B1 |
13 May, 2020
|
A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation
|
Jul, 2034
|
2
| |
|
EP2568968B1 |
12 Jul, 2017
|
Manufacturing Of Active-Free Granules And Tablets Comprising The Same
|
May, 2031
|
1
| |
|
EP1586311B1 |
03 May, 2017
|
Melt Extrusion Of Multiparticulates
|
Feb, 2025
|
1
| |
